The team at XVIVO Scientific Animation partnered with scientists at IBM Research in Zurich Switzerland to illustrate their advances in computational memory devices, which were published in the April 2018 issue of Nature Electronics. XVIVO developed an illustration to
Biopharmaceutical company, Symic Bio, recently announced 12-month results from SB-030 trial evaluating SB-030 in patients with peripheral vascular disease undergoing angioplasty. The results demonstrate improvement in efficacy outcome. We congratulate Symic Bio on these encouraging results! XVIVO had the
Alternating electrical fields can be used to treat tumors noninvasively. These fields, termed tumor treating fields (or TTFs), are low-intensity waves with an operating frequency of hundreds of kHz. The TTFs selectively disrupt mitosis in dividing cancer cells, thereby arresting
The team at XVIVO Scientific Animation is hitting the road to showcase their newest capabilities in virtual reality (VR) for interactive medical visualizations. In the latest fully-interactive experience they’ve developed, running on an Oculus Rift, you are a drug delivery
Cheers to a new year! Had a ball with my team at the XVIVO holiday party, it was a great year…looking forward to 2018! Could not have done it without this XVIVO Family. Here are some highlights!